Clinical value of the ovarian reserve in reproductive function


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper outlines present-day views on the ovarian reserve. It considers different exogenous and endogenous factors giving rise to premature ovarian reserve exhaustion. The role of surgical interventions into reproductive organs is covered in the light of further reproductive function. An understanding of the pathological mechanisms that act on ovarian tissue will be able to improve diagnostic methods and to predict fertility techniques.

Full Text

Restricted Access

About the authors

A. S Gasparov

Peoples' Friendship University of Russia

Email: 5454444@mail.ru
MD, professor of the Department of obstetrics & gynecology

E. D Dubinskaya

Peoples' Friendship University of Russia

Email: eka-dubinskaya@yandex.ru
MD, D. Sc in Medicine, associate professor of the Department of obstetrics & gynecology

D. S Titov

United Hospital and Polyclinic

Email: ginekologija@rambler.ru
assistant professor of the Department of obstetrics & gynecology

N. V Lapteva

Peoples' Friendship University of Russia

Email: nvlapteva@gmail.com
assistant professor of the Department of obstetrics & gynecology

References

  1. Kyrou D., Kolibianakis E., Venetis C.A., Papanikolaou E.G., Bontis J., Tarlatzis B.C. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil. Steril. 2009; 91(2): 749-66.
  2. Loutradis D., Vomvolaki E., Drakakis P. Poor responder protocols for in-vitro fertilization: options and results. Curr. Opin. Obstet. Gynecol. 2008; 20(4): 374-8.
  3. Ferraretti A.P., La Marca A., Fauser B.C., Tarlatzis B., Nargund G., Gianaroli L.; ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum. Reprod. 2011; 26(7): 1616-24.
  4. Broer S.L., Eijkemans M.J., Scheffer G.J., van Rooij I.A., de Vet A., Themmen A.P. et al. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J. Clin. Endocrinol. Metab. 2011; 96(8): 2532-9.
  5. Pandian Z., McTavish A.R., Aucott L., Hamilton M.P., Bhattacharya S. Interventions for ‘poor responders’ to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst. Rev. 2010; (1): CD004379. doi: 10.1002/14651858. CD004379.pub3
  6. Check J.H. Understanding the physiology of folliculogenesis serves as the foundation for perfecting diagnosis and treatment of ovulatory defects. Clin. Exp. Obstet. Gynecol. 2012; 39(3): 273-9
  7. Боярский К.Ю., Гайдуков С.Н., Чкуасели А.С. Факторы, определяющие овариальный резерв. Журнал акушерства и женских болезней. 2009; 2: 65-71
  8. Боярский К.Ю. Роль показателей овариального резерва при лечении бесплодия методом ЭКО и ПЭ. В кн.: Кулаков В.И., Леонов Б.В., Кузьмичев Л.Н., ред. Лечение женского и мужского бесплодия (вспомогательные репродуктивные технологии). М.: МИА; 2005: 53-60
  9. Weghofer A., Kim A., Barad D.H., Gleicher N. Follicle stimulating hormone and anti-Müllerian hormone per oocyte in predicting in vitro fertilization pregnancy in high responders: a cohort study. PLoS One. 2012; 7(4): e34290.
  10. Gougeon A. All about follicles. Gynecol. Obstet. Fertil. 2010; 38(6): 394.
  11. Dolleman M., Faddy M.J., van Disseldorp J., van der Schouw Y.T., Messow C.M., Leader B. et al. The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies. J. Clin. Endocrinol. Metab. 2013; 98(5): 1946-53.
  12. The menopausal transition. Practice Committee of the American Society for Reproductive Medicine. Fertil. Steril. 2008; 90(Suppl.3): S61-5.
  13. De Vos M., Devroey P., Fauser B.C. Primary ovarian insufficiency. Lancet. 2010; 376(9744): 911-21.
  14. Gleicher N., Weghofer A., Oktay K., Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod. Biomed. Online. 2009; 19: 385-90.
  15. La Marca A., Brozzetti A., Sighinolfi G., Marzotti S., Volpe A., Falorni A. Primary ovarian insufficiency: autoimmune causes. Curr. Opin. Obste.t Gynecol. 2010; 22(4): 277-82.
  16. Jin M., Yu Y., Huang H. An update on primary ovarian insufficiency. Sci. China Life Sci. 2012; 55(8): 677-86.
  17. Okeke T., Anyaehie U., Ezenyeaku C. Premature menopause. Ann. Med. Health Sci. Res. 2013; 3(1): 90-5.
  18. Fréour T., Jean M., Mirallie S., Barriere P. Computer-assisted sperm analysis parameters in young fertile sperm donors and relationship with age. Syst. Biol. Reprod. Med. 2012; 58(2): 102-6.
  19. Utkin E.V., Podonina N.M., Kordubalova N.I. Role and place of antibacterial therapy in prophylaxis of disturbances in reproductive function of women. Antibiot. Khimioter. 2012; 57(7-8): 38-42.
  20. Sowers M.R., Mc Connell D., Yosef M., Jannausch M.L., Harlow S.D. Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period. Ann. N. Y. Acad. Sci. 2010; 1204: 95-103.
  21. Freour T., Dessolle L., Jean M., Masson D., Barriere P. Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF. Reprod. Biomed. Online. 2010; 20(6): 857-60.
  22. Benedict M.D., Missmer S.A., Ferguson K.K., Vitonis A.F., Cramer D.W., Meeker J.D. Secondhand tobacco smoke exposure is associated with prolactin but not thyroid stimulating hormone among nonsmoking women seeking in vitro fertilization. Environ. Toxicol. Pharmacol. 2012; 34(3): 761-7.
  23. Dechanet C., Anahory T., Mathieu Daude J.C., Quantin X., Reyftmann L., Hamamah S. et al. Effects of cigarette smoking on reproduction. Hum. Reprod. Update. 2011; 17(1): 76-95.
  24. Dechanet C., Brunet C., Anahory T., Hamamah S., Hedon B., Dechaud H. Effects of cigarette smoking on female reproduction: from oocyte to embryo (Part I). Gynecol. Obstet. Fertil. 2011; 39(10): 559-66.
  25. Rickert W.S., Trivedi A.H., Momin R.A., Wagstaff W.G., Lauterbach J.H. Mutagenic, cytotoxic, and genotoxic properties of tobacco smoke produced by cigarillos available on the Canadian market. Regul. Toxicol. Pharmacol. 2011; 61(2): 199-209.
  26. Fuentes A., Munoz A., Pommer R., Argüello B., Galleguillos A., Torres A., Jesam C. Decreased anti-Müllerian hormone concentration in follicular fluid of female smokers undergoing artificial reproductive techniques. Chemosphere. 2012; 88(4): 403-6.
  27. Stangel-Wojcikiewicz K., Zdebik A., Jach R., Huras H., Wadowska-Jaszczynska K., Radon-Pokracka M. et al. Hormone replacement therapy regimens in chemotherapy-induced premature ovarian failure and the subsequent correction of hormone levels. Neuro Endocrinol. Lett. 2012; 33(7): 697-702.
  28. Van Dorp W., van den Heuvel-Eibrink M.M., Stolk L., Pieters R., Uitterlinden A.G., Visser J.A., Laven J.S.E. Genetic variation may modify ovarian reserve in female childhood cancer survivors. Hum. Reprod. 2013; 28(4): 1069-76.
  29. Oktem O., Oktay K. Fertility preservation for breast cancer patients. Semin. Reprod. Med. 2009; 27(6): 486-92.
  30. Atabekoglu C., Ta§kin S., Kahraman K., Gemici A., Taşkin E.A., Ozmen B. et al. The effect of total abdominal hysterectomy on serum anti-Müllerian hormone levels: a pilot study. Climacteric. 2012; 15(4): 393-7.
  31. Bouwsma E.V., Hesley G.K., Woodrum D.A., Weaver A.L., Leppert P.C., Peterson L.G., Stewart E.A. Comparing focused ultrasound and uterine artery embolization for uterine fibroids-rationale and design of the Fibroid Interventions: reducing symptoms today and tomorrow (FIRSTT) trial. Fertil. Steril. 2011; 96(3): 704-10.
  32. Biacchiardi C.P., Piane L.D., Camanni M., Deltetto F., Delpiano E.M., Marchino G.L. et al. Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons. Reprod. Biomed Online. 2011; 23(6): 740-6.
  33. Celik H.G., Dogan E., Okyay E., Ulukus C., Saatli B., Uysal S., Koyuncuoglu M. Effect of laparoscopic excision of endometriomas on ovarian reserve: serial changes in the serum antimüllerian hormone levels. Fertil. Steril. 2012; 97(6): 1472-8.
  34. Raff F., Metwally M., Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2012; 97(9): 3146-54.
  35. Raff F., Shaw R.W., Amer S.A. National survey of the current management of endometriomas in women undergoing assisted reproductive treatment. Hum. Reprod. 2012; 27(9): 2712-9.
  36. Suksompong S., Dejarkom S., Petyim S., Dangrat C., Orachon D., Choavaratana R. Ovarian reserve evaluation by anti-mullerian hormone in women undergoing laparoscopic cystectomy of endometrioma. J. Med. Assoc. Thai. 2012; 95(11): 1389-95.
  37. Rustamov O., Smith A., Roberts S.A., Yates A.P., Fitzgerald C., Krishnan M. et al. Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability. Hum. Reprod. 2012; 27(10): 3085-91.
  38. Roy K.K., Baruah J., Moda N., Kumar S. Evaluation of unilateral versus bilateral ovarian drilling in clomiphene citrate resistant cases of polycystic ovarian syndrome. Arch. Gynecol. Obstet. 2009; 280(4): 573-8.
  39. Sunj M., Canic T., Baldani D.P., Tandara M., Jeroncic A., Palada I. Does unilateral laparoscopic diathermy adjusted to ovarian volume increase the chances of ovulation in women with polycystic ovary syndrome? Hum. Reprod. 2013; 28(9): 2417-24.
  40. Carmina E., Campagna A.M., Lobo R.A. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors. Hum. Reprod. 2013; 28(8): 2245-52.
  41. Abu Hashim H., Al-Inany H., De Vos M., Tournaye H. Three decades after Gjönnaess’s laparoscopic ovarian drilling for treatment of PCOS; what do we know? An evidence-based approach. Arch. Gynecol. Obstet. 2013; 288(2): 409-22.
  42. Benaglia L., Somigliana E., Vighi V., Ragni G., Vercellini P., Fedele L. Rate of severe ovarian damage following surgery for endometriomas. Hum. Reprod. 2010; 25(3): 678-82.
  43. Garcia-Velasco J.A., Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum. Reprod. 2009; 24(3): 496-501.
  44. Benaglia L., Somigliana E., Vercellini P., Abbiati A., Ragni G., Fedele L. Endometriotic ovarian cysts do not negatively affect the rate of spontaneous ovulation. Hum. Reprod. 2009; 24(9): 2183-6. doi: 10.1093/humrep/dep202.
  45. Hwu Y.M., Wu F.S., Li S.H., Sun F.J., Lin M.H., Lee R.K. The impact of endometrioma and laparoscopic cystectomy on serum anti-Müllerian hormone levels. Reprod. Biol. Endocrinol. 2011; 9: 80.
  46. Uncu G., Kasapoglu I., Ozerkan K., Seyhan A., Oral Yilmaztepe A., Ata B. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Hum. Reprod. 2013; 28(8): 2140-5.
  47. Гаспаров А.С., Дубинская Е.Д., Дмитриева Н.В., Яковенко С.А. Отдаленные результаты лечения бесплодия с использованием вспомогательных репродуктивных технологий у пациенток с эндомет-риоидными кистами яичников. В кн.: VI Общероссийский научнопрактический семинар с международным участием «Репродуктивный потенциал России: версии и контраверсии». Сочи, 7-10 сентября 2013: 18.
  48. Jersus J., Woodruff T. Preservation of fertility in patients with cancer. N. Engl. J. Med. 2009; 360: 902-11

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies